The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Harvey, P. D.
* Articles by Brickman, A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Harvey, P. D.
* Articles by Brickman, A.
Related Collections
* Schizophrenia Spectrum Disorders
* Cognition
Am J Psychiatry 162:110-117, January 2005
© 2005 American Psychiatric Association

Stability of Cognitive Performance in Older Patients With Schizophrenia: An 8-Week Test-Retest Study

Philip D. Harvey, Ph.D., Barton W. Palmer, Ph.D., Robert K. Heaton, Ph.D., Somaia Mohamed, M.D., Ph.D., John Kennedy, M.D., and Adam Brickman, M.A.

OBJECTIVE: It is important to understand the stability of cognitive performance in schizophrenia in order to understand 1) the potential improvements in performance associated with the beneficial effects of cognitive-enhancing medications and 2) the potential variation in performance on cognitive measures that are components of neuroimaging studies. There are several factors that could lead to spurious improvements in cognitive test scores, including practice effects and random test-retest errors. METHOD: Forty-five older patients with schizophrenia who were receiving conventional antipsychotic medications participated in the study. All subjects completed a comprehensive neuropsychological test battery at baseline and again at an 8-week follow-up evaluation. RESULTS: Performance on all of the cognitive measures was stable over time, as evidenced by significant test-retest correlations, and practice effects were generally absent or minimal. Tests administered with alternate forms were no more temporally stable than tests administered twice with the same form. Very few individual cases had substantial variation at retest across the 22 test scores. From these data, "norms for evaluating change" were developed and described using the reliable change index method. CONCLUSIONS: The data suggest that the findings of modest cognitive improvements seen in some prior studies of schizophrenia patients when treated with second-generation antipsychotic medications were probably not due to simple retesting artifacts. At the same time, because of the variance in some of these test-retest performances, relatively substantial changes in performance on the part of individual patients would be required to be clearly interpretable.




This article has been cited by other articles:


Home page
Schizophr BullHome page
D. Dickinson and J. M. Gold
Less Unique Variance Than Meets the Eye: Overlap Among Traditional Neuropsychological Dimensions in Schizophrenia
Schizophr Bull, May 1, 2008; 34(3): 423 - 434.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
A. Szoke, A. Trandafir, M.-E. Dupont, A. Meary, F. Schurhoff, and M. Leboyer
Longitudinal studies of cognition in schizophrenia: meta-analysis
The British Journal of Psychiatry, April 1, 2008; 192(4): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
T. E. Goldberg, R. S. Goldman, K. E. Burdick, A. K. Malhotra, T. Lencz, R. C. Patel, M. G. Woerner, N. R. Schooler, J. M. Kane, and D. G. Robinson
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Arch Gen Psychiatry, October 1, 2007; 64(10): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
P. D. Harvey, D. I. Velligan, and A. S. Bellack
Performance-Based Measures of Functional Skills: Usefulness in Clinical Treatment Studies
Schizophr Bull, September 1, 2007; 33(5): 1138 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. E. Gur, M. E. Calkins, R. C. Gur, W. P. Horan, K. H. Nuechterlein, L. J. Seidman, and W. S. Stone
The Consortium on the Genetics of Schizophrenia: Neurocognitive Endophenotypes
Schizophr Bull, January 1, 2007; 33(1): 49 - 68.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
P. D. Harvey, T. L. Patterson, L. S. Potter, K. Zhong, and M. Brecher
Improvement in Social Competence With Short-Term Atypical Antipsychotic Treatment: A Randomized, Double-Blind Comparison of Quetiapine Versus Risperidone for Social Competence, Social Cognition, and Neuropsychological Functioning
Am J Psychiatry, November 1, 2006; 163(11): 1918 - 1925.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org